Activation of immune-mediated inflammatory pathways appears central to the pathogenesis of rosacea and involves the coordinated activity of several cell types, such as mast cells and macrophages, and the release of proinflammatory mediators, such as IL-6, IL-1β, and TNF-α (32, 33). The gene discussed is IL1B; the disease is rosacea.